Bayhill Therapeutics files for $86.25 mln IPO
Jan 9 (Reuters) - Drug company Bayhill Therapeutics Inc filed with U.S. regulators on Wednesday to raise up to $86.25 million in an initial public offering of common stock.
The Palo Alto, California-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus that Pacific Growth Equities LLC, Lazard Capital Markets, Merriman Curhan Ford & Co and Punk, Ziegel & Co were underwriting the IPO.
The company intends to list its common stock on the Nasdaq under the symbol "BHTX." (Reporting by Varsha Tickoo in Bangalore; Editing by Himani Sarkar)